Public Citizen seeks Crestor investigation
Executive Summary
Public Citizen calls for a criminal investigation of AstraZeneca "for illegally delaying the submission to the FDA of 23 reports of serious adverse reactions" for Crestor (rosuvastatin) in Aug. 3 letter to FDA. AstraZeneca maintains that rhabdomyolysis and acute renal failure are labeled events that do not require 15-day alert reports. Public Citizen filed a petition in March calling for Crestor's withdrawal (1"The Pink Sheet" May 24, 2004, p. 11)...